Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: placebo|DRUG: interleukin 7|DRUG: interleukin 7|DRUG: interleukin 7
Sponsor: Centre Leon Berard
Collaborators: Ministry of Health, France|Cytheris, Inc.